Intel shares dropped 25% in pre-market US trading to 68.29 US dollars on October 30, 2026, after the chipmaker issued a weaker-than-expected quarterly forecast. According to live.deutsche-boerse.com, the company cited a surge in memory chip prices that slowed personal computer sales, alongside supply chain disruptions for high-demand data center components.
Intel and Amazon Post Divergent Third-Quarter Results Amid Supply and AI Pressures
Here is the math on the broader technology sector split. While Intel (NASDAQ: INTC) struggled with component costs, Amazon (NASDAQ: AMZN) reported that its cloud division, Amazon Web Services (AWS), accelerated revenue growth by 39% year-over-year to 46 billion US dollars in the third quarter. AWS generated an operating income of 17.8 billion US dollars, marking a 55% increase from the previous year. Despite the cloud gains, Amazon shares fell as investors weighed heavy capital expenditures on AI data centers against holiday shopping forecasts.
But the balance sheet tells a different story across other global industries on Friday. In the pharmaceutical sector, AstraZeneca (NASDAQ: AZN) saw its shares climb after posting a 7% revenue increase to roughly 16.2 billion US dollars, driven by cancer drug sales. Net income for AstraZeneca jumped 25% to 3.1 billion US dollars, beating analyst expectations for earnings per share.
Bayer Cleared in Missouri Glyphosat Trial as Chevron Surpasses Profit Estimates
Legal and commodity pressures shifted market leadership elsewhere in global indices. A Missouri jury handed Bayer (ETR: BAYN) a unanimous verdict in a glyphosate lawsuit overnight, bolstering the company’s settlement strategy following a favorable US Supreme Court ruling in June. Bayer shares rose to 49.99 Euros, leading the DAX index.
Meanwhile, rising crude oil prices and expanding refinery margins drove Chevron (NYSE: CVX) to nearly triple its third-quarter profit to 9.9 billion US dollars compared to the previous year. Chevron’s adjusted earnings per share reached 5.28 US dollars, topping consensus estimates and lifting the stock by 1.5% in pre-market trading.
| Company | Ticker | Q3 Metric / Event | Market Response |
|---|---|---|---|
| Amazon | NASDAQ: AMZN | AWS revenue up 39% to $46B | Shares down on AI spending |
| Bayer | ETR: BAYN | Unanimous Missouri glyphosate verdict | Rose to €49.99 (DAX leader) |
| Chevron | NYSE: CVX | Adjusted EPS up to $5.28; profit near $9.9B | Up ~1.5% pre-market |
Evonik Rejects BASF Takeover Approach While Volkswagen Halts E-Golf Development
Corporate consolidation efforts faced resistance in Germany. Specialty chemicals producer Evonik (ETR: EVNK) announced it rejected an acquisition approach from competitor BASF (ETR: BAS) after reviewing the proposal. Evonik stated it will focus on independent development, though it remains open to confidential, informative exchanges.
Automotive headwinds also persisted. Volkswagen (ETR: VOW3) suspended development work on its upcoming all-electric Golf model at its main plant in Wolfsburg. Brand Chief Financial Officer David Powels stated the measure will stay in place until necessary investments can be securely absorbed amid ongoing cost-cutting efforts.
In the digital asset space, cryptocurrency exchange Binance confirmed a major security breach involving an estimated 6.3 billion US dollars in affected user funds, prompting a temporary suspension of all deposits and withdrawals.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
